Glial cells in chronic inflammation: diversity, dysfunction and therapeutic targeting

Area of Science:

• Neuroimmunology
• Central Nervous System (CNS) Inflammation
• Glial Cell Biology

Background:

• Multiple sclerosis (MS) is a chronic CNS inflammatory disease.
• Current MS therapies target the peripheral immune system, neglecting CNS mechanisms.
• Disease progression involves CNS-resident glial cells like astrocytes, microglia, and oligodendrocytes.

Purpose of the Study:

• To review emerging insights into glial cell diversity, function, and regulation in MS.
• To highlight glial cell interactions with other CNS cells.
• To discuss potential therapeutic strategies targeting glial cells.

Main Methods:

• Review of recent scientific literature and technological advancements.
• Analysis of glial cell heterogeneity and functional roles.
• Synthesis of information on glial cell interactions and therapeutic potential.

Main Results:

• Glial cells (astrocytes, microglia, oligodendrocytes) are functionally diverse and crucial in MS.
• These cells play key roles in CNS inflammation, demyelination, remyelination, and neurodegeneration.
• Glial cell interactions with immune and non-immune cells are central to MS pathogenesis.

Conclusions:

• Understanding glial cell heterogeneity is vital for MS research.
• Targeting CNS-resident glial cells offers promising therapeutic avenues for MS.
• Future MS therapies may focus on modulating glial cell functions within the CNS.